About This Article
To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight/obese patients with co-morbidities, with and without type 2 diabetes (T2D).
![Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Ascending Doses Of The Novel Long-Acting Glucagon Analogue HM15136 In Overweight And Obese Patients With Co-Morbidities thumbnail](https://prosciento.com/wp-content/uploads/2023/07/Diabetes-Obesity-Metabolism-2023-Shin-Safety-tolerability-pharmacokinetics-pharmacodynamics-thumb.jpg)